NU6027 - HY-13816
Nur noch %1 verfügbar
Catalog #
HY-13816
Ab
80,00 €
NU6027 is a potent and ATP-competitive inhibitor of both CDK1 and CDK2, with Kis of 2.5 μM and 1.3 μM, respectively. NU6027 is also a potent inhibitor of ATR and enhances hydroxyurea and cisplatin cytotoxicity in an ATR-dependent manner[1][2].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-13816/NU6027-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Cancer-Kinase/protease |
| CAS | 220036-08-8 |
| Storage | 4°C (Powder, protect from light) |
| MWT | 251.28 |
| Solubility | DMSO : 12.5 mg/mL (ultrasonic;warming;heat to 60°C) |
| Clinical Information | No Development Reported |
| Target | ATM/ATR;CDK |
| Application: | Cancer-Kinase/protease |
|---|